Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro
Bart S. Hendriks(Pfizer (United States)), J Chabot(Pfizer (United States))
Cited by 18
Related Papers
Parsing ERK Activation Reveals Quantitatively Equivalent Contributions from Epidermal Growth Factor Receptor and HER2 in Human Mammary Epithelial Cells
|Journal of Biological Chemistry|2004|77